PADI4 and ovarian cancer: Increased PAD4 expression has been observed in SKOV-3 ovarian cancer cells incubated with 17β-estradiol (E2), and this increased expression showed a dose-dependent positive correlation with E2 concentrations in the ranging from 10–10 to 10–4 M [235].